These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7470173)

  • 1. Deficiency of C7 with systemic lupus erythematosus: solubilization of immune complexes in complement-deficient sera.
    Zeitz HJ; Miller GW; Lint TF; Ali MA; Gewurz H
    Arthritis Rheum; 1981 Jan; 24(1):87-93. PubMed ID: 7470173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complement deficiency, immunocomplexes and lupus erythematosus].
    Vivanco Martínez F
    Rev Clin Esp; 1987 Mar; 180(5):264-8. PubMed ID: 3602524
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G
    Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement deficiency. Predisposing factor to autoimmune syndromes.
    Atkinson JP
    Am J Med; 1988 Dec; 85(6A):45-7. PubMed ID: 3202107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
    Balestrieri G; Pagani D; Tincani A
    J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solubility of immune complexes and activity of the alternative complement pathway in patients with systemic lupus erythematosus].
    Riera Cervantes N; Geffner J; Isturiz MA; Manni JA; de Bracco MM
    Rev Clin Esp; 1985 Oct; 177(6):254-7. PubMed ID: 4081196
    [No Abstract]   [Full Text] [Related]  

  • 10. C3 receptors, complement deficiency and SLE.
    Walport M; Lachmann P
    Br J Rheumatol; 1984 Feb; 23(1):3-5. PubMed ID: 6697070
    [No Abstract]   [Full Text] [Related]  

  • 11. Component deficiencies. 7. The seventh component.
    Zeitz HJ; Lint TF; Gewurz A; Gewurz H
    Prog Allergy; 1986; 39():289-94. PubMed ID: 3562469
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulating immune complexes in systemic lupus erythematosus].
    Font J; Cardellach F; Mirapeix E; Martorell J; Ingelmo M
    Med Clin (Barc); 1982 Dec 1-31; 79(10):478. PubMed ID: 7154732
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus.
    Aguado MT; Perrin LH; Miescher PA; Lambert PH
    Arthritis Rheum; 1981 Oct; 24(10):1225-9. PubMed ID: 7306225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited complement deficiencies.
    Lachmann PJ
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):419-30. PubMed ID: 6149584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-mediated solubilization of immune complexes. Solubilization inhibition and complement factor levels in SLE patients.
    Baatrup G; Petersen I; Kappelgaard E; Jepsen HH; Svehag SE
    Clin Exp Immunol; 1984 Feb; 55(2):313-8. PubMed ID: 6230182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement deficiency states.
    Agnello V
    Medicine (Baltimore); 1978 Jan; 57(1):1-23. PubMed ID: 337041
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE).
    Segurado OG; Arnaiz-Villena AA; Iglesias-Casarrubios P; Martinez-Laso J; Vicario JL; Fontan G; Lopez-Trascasa M
    Clin Exp Immunol; 1992 Mar; 87(3):410-4. PubMed ID: 1347491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA; Morris SM; Dash A; Peters DK
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement in the aetiopathogenesis of systemic lupus erythematosus.
    Gatenby PA
    Autoimmunity; 1991; 11(1):61-6. PubMed ID: 1839881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.